Skip to main content

Journal of Cancer Research and Clinical Oncology

Ausgabe 4/2011

Inhalt (20 Artikel)

Original Paper

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis

Wen Gao, Hua Shen, Lingxiang Liu, Jian Xu, Jing Xu, Yongqian Shu

Original Paper

Pathobiological features of small hepatocellular carcinoma: correlation between tumor size and biological behavior

Xin-Yuan Lu, Tao Xi, Wan-Yee Lau, Hui Dong, Zhi-Hong Xian, Hua Yu, Zhen Zhu, Feng Shen, Meng-Chao Wu, Wen-Ming Cong

Original Paper

Molecular and histological evaluation of tumor necrosis factor-alpha expression in Helicobacter pylori-mediated gastric carcinogenesis

Cinghu Senthilkumar, Sivasithambaram Niranjali, Venkatraman Jayanthi, Thiyagarajan Ramesh, Halagowder Devaraj

Original Paper

Osteosarcoma: improvement in survival limited to high-grade patients only

Muhammad Umar Jawad, Michael C. Cheung, Jennifer Clarke, Leonidas G. Koniaris, Sean P. Scully

Original Paper

Cancer in cohort of HIV-infected population: prevalence and clinical characteristics

Yong-xi Zhang, Xi-en Gui, Ya-hua Zhong, Yu-ping Rong, Ya-jun Yan

Original Paper

Expression of the Wnt antagonist DKK3 is frequently suppressed in sporadic epithelial ovarian cancer

An You, Emmanouil Fokas, Lin-Fang Wang, Haitao He, Beate Kleb, Dieter Niederacher, Rita Engenhart-Cabillic, Han-Xiang An

Original Paper

Iron containing anti-tumoral agents: unexpected apoptosis-inducing activity of a ferrocene amino acid derivative

Benjamin Kater, Andrea Hunold, Hans-G. Schmalz, Lisa Kater, Birgit Bonitzki, Patrick Jesse, Aram Prokop

Original Paper

Preoperative serum retinol-binding protein 4 is associated with the prognosis of patients with hepatocellular carcinoma after curative resection

Dan-Dan Wang, Yi-Ming Zhao, Lu Wang, Guang Ren, Fei Wang, Zu-Guang Xia, Xi-Long Wang, Tao Zhang, Qi Pan, Zhi Dai, Ju-Ping Chen, Hai-Yan Dai, Wei Zhang, Hong-Wei He, Jia-Min Zhou, Guang-Yu Tang, Jian Zhou, Jia Fan, Zhao-You Tang

Original Paper

Long-term clinical outcomes of hepatic arterial infusion chemotherapy with cisplatin with or without 5-fluorouracil in locally advanced hepatocellular carcinoma

Beom Kyung Kim, Jun Yong Park, Hye Jin Choi, Do Young Kim, Sang Hoon Ahn, Ja Kyung Kim, Do Youn Lee, Kwang Hoon Lee, Kwang-Hyub Han

Original Paper

Evaluating mitochondrial DNA in patients with breast cancer and benign breast disease

Lijun Shen, Jia Wei, Tao Chen, Jing He, Jianchun Qu, Xiumei He, Luxi Jiang, Yemin Qu, Hezhi Fang, Guorong Chen, Jianxin Lu, Yidong Bai

Original Paper

Chemopreventive effects of zinc on prostate carcinogenesis induced by N-methyl-N-nitrosourea and testosterone in adult male Sprague-Dawley rats

S. Banudevi, P. Elumalai, R. Arunkumar, K. Senthilkumar, D. N. Gunadharini, G. Sharmila, J. Arunakaran

Original Paper

The different efficacy of gefitinib or erlotinib according to epidermal growth factor receptor exon 19 and exon 21 mutations in Korean non-small cell lung cancer patients

Jong-Mu Sun, Young-Woong Won, Seung Tae Kim, Jung Hoon Kim, Yoon-La Choi, Jeeyun Lee, Yeon Hee Park, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn

Original Paper

Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma

Guoqiang Li, Xiaofeng Wu, Feng Zhang, Xiangcheng Li, Beicheng Sun, Yue Yu, Aihong Yin, Lei Deng, Jie Yin, Xuehao Wang

Original Paper

RIPK1 and CASP7 polymorphism as prognostic markers for survival in patients with colorectal cancer after complete resection

Yee Soo Chae, Jong Gwang Kim, Sang Kyun Sohn, Su Jeong Lee, Byung Woog Kang, Joon Ho Moon, Jae Yong Park, Seong Woo Jeon, Han-Ik Bae, Gyu Seog Choi, Soo-Han Jun

Original Paper

CRABP1-reduced expression is associated with poorer prognosis in serous and clear cell ovarian adenocarcinoma

Takahito Miyake, Yutaka Ueda, Shinya Matsuzaki, Takashi Miyatake, Kiyoshi Yoshino, Masami Fujita, Taisei Nomura, Takayuki Enomoto, Tadashi Kimura

Original Paper

Involvement of PTEN/Akt signaling in capsular invasive carcinomas developed in a rat two-stage thyroid carcinogenesis model after promotion with sulfadimethoxine

Sayaka Kemmochi, Hitoshi Fujimoto, Gye-Hyeong Woo, Kaoru Inoue, Miwa Takahashi, Kunitoshi Mitsumori, Masao Hirose, Akiyoshi Nishikawa, Makoto Shibutani

Original Paper

Results of comprehensive geriatric assessment effect survival in patients with malignant lymphoma

Nils Winkelmann, Iver Petersen, Michael Kiehntopf, Hans Joerg Fricke, Andreas Hochhaus, Ulrich Wedding

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.